期刊文献+

活性氧介导铁过载对脐带间充质干细胞及其造血支持作用的研究 被引量:5

Reactive oxygen species mediate the injury and deficient hematopoietic supportive capacity of umbilical cord derived mesenchymai stem cells induced by iron overload
原文传递
导出
摘要 目的探讨铁过载对脐带间充质干细胞(UC-MSC)的损伤作用及活性氧物质(ROS)在该机制中的意义。方法体外培养UC.MSC,用不同浓度的枸橼酸铁胺(FAC)处理UC-MSC不同时间建立铁过载模型。采用细胞倍增时间计算细胞的增殖能力;用AnnexinV/PI双染法检测细胞的凋亡;用共培养方法检测UC-MSC的造血支持能力;并用DCFH-DA荧光探针检测细胞内ROS水平;Western印迹法检测铁过载及抗氧化处理后UC-MSC内ROS相关信号蛋白p-p38MAPK、p38MAPK及1953的表达。结果(1)加铁组UC-MSC的群体倍增时间明显长于对照组[第3代细胞:(24.43±2.72)h比(16.03±2.31)h,P〈0.05],但传代次数增加2代后两组之间差异无统计学意义(P〉0.05);(2)加铁组UC-MSC的凋亡率(12.75%±0.32%)明显高于对照组(3.63%±0.80%)(P〈0.05);(3)脐血单个核细胞(MNC)与加铁组UC-MSC共培养1和2周时,其造血集落形成能力均明显低于对照组(均P〈0.05);(4)加铁组UC-MSC内ROS水平明显高于对照组,且ROS的水平呈时间与浓度依赖性,在400LLm0L/LFAC浓度下作用12h达到最高值(1499±86比548±97,P〈0.05);(5)加铁组UC-MSC的p-p38MAPK、P53蛋白表达明显高于对照组,当给予抗氧化剂处理后,相关信号通路可被抑制。结论铁过载可能通过激活ROS相关信号传导因子p-p38MAPK、1953抑制UC-MSC的增殖能力,诱导其凋亡,降低其造血支持能力。 Objective To explore the effects of iron overload on umbilical cord derived mesenchymal stem cells (UC-MSC) and elucidate the involvement of reactive oxygen species (ROS) in this process. Methods The iron overload model of MSC was established by in vitro addition of ferric ammonium citrate (FAC) into culture medium. Cell proliferation and apoptosis were determined by Annexin V/PI double staining and population doubling time (DT) respectively. Co-culture system was used to assess the hematopoietic support capacity of UC-MSC in different groups. Thereafter the ROS level was detected with fluorescent probe 2' ,7'-dichlorofluorescin diaeetate (DCFH-DA). And the ROS related signaling factors of p-p38MAPK, p38 MAPK, P53 were measured by Western blot. Results ( 1 ) The DT of UC-MSC in iron overload group was significantly longer than that of control ( (24.43 ± 2. 72) h vs( 16. 03 ± 2. 31 ) h,P 〈 0. 05 ). But the difference was insignificant after two passages ( P 〉 0. 05 ). (2) Apoptosis in iron overload group was higher than that of control ( 12. 75% ±0. 32% vs 3.63% ±0. 80% , P 〈0.05). (3)The colony forming capacity of mononuclear cell (MNC) co-cultured with UC-MSC of iron overload group for 1/2 weeks significantly decreased. (4)The ROS level of UC-MSC with iron overload was higher than that of control in time and concentration-dependent fashions and it peaked at 400 μmol/L of FAC for 12 h ( 1499 ± 86 vs 548 ± 97,P 〈 0. 05). (5)The expressions of p-p38MAPK and P53 increased in response to FAC compared with control. But such an effect was partially inhibited after the use of antioxidants. Conclusions Ironoverload may impair the proliferation, survival and hematopoeisis supportive function of UC-MSC by enhancing the generation of ROS. And ROS stimulates the signaling pathways of p-p38MAPK and P53.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第12期930-934,共5页 National Medical Journal of China
基金 国家自然科学基金(81041043) 教育部留学归国人员科研启动基金(教外司留[2007]1108) 天津市卫生局科技基金重点项目(2011KR01)
关键词 铁超负荷 间质干细胞 脐带 活性氧物质 信号传导 Iron overload Mesenchymal stem-cells Umbilical cord Reactive oxygenspecies Signal transduction
  • 相关文献

参考文献14

  • 1Valko M, Rhodes C J, Moncol J, et al. Free radical, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact ,2006,160 : 1-40.
  • 2Gattermann N, Finelli C, Della Porta M, et al. Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes. Haematologica, 2012,97 : 1364- 1371.
  • 3Zhao MF, Xie F, Li YM, et al. Increased intracellular concentration of reactive oxygen species mediated the deficient hematopoiesis of iron overload bone marrow//ASH Annual Meeting. Blood, 2010 : 4247a[2012-09-05].http://abstracts. hematologylibrary, org/ cgi/content /abstract/l16/21/42477 maxtoshow = &hits = lO& RESULTFOR MAT = &fulltext = I&FIRSTINDEX = 0&sortspec HWCIT mingfeng + zhao&searchid = = relevance& resourcetype =.
  • 4谢芳,赵明峰,朱海波,卢文艺,徐新女,肖霞,穆娟,刘鹏江,李玉明.氧化应激对铁过载造血干祖细胞造血功能的影响[J].中华医学杂志,2011,91(46):3284-3288. 被引量:12
  • 5谢芳,赵明峰,李玉明,朱海波,江燕,徐新女,肖霞,穆娟,刘鹏江,吕海蓉.铁过载诱导活性氧物质生成对骨髓造血功能影响的体外实验研究[J].中华血液学杂志,2011,32(9):606-609. 被引量:14
  • 6Taoka K, Kumano K, Nakamura F, et al. The effect of iron overload and chelation on erythroid differentiation. Int J Hematol,2012,95: 149-159.
  • 7Prus E, Fibach E. Flow cytometry measurement of the labile iron pool in human hematopoietic cells. Cytometry A,2008,73:22-27.
  • 8Bakhshi T, Zabriskie RC, Bodie S, et al. Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem ceils daring long-term ex vivo culture. Transfusion, 2008,48:2638- 2644.
  • 9Wang G,Gong Y, Burczynski FJ, et al. Cell lysis with dimethyl sulphoxide produces stable homogeneous solutions in the dichlorofluorescein oxidative stress assay. Free Radic Res, 2008, 42:435-441.
  • 10Guariglia R, Martorelli MC, Villani O, et al. Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy : a brief review. Leuk Res, 2011,35:566-570.

二级参考文献23

  • 1Lipinski P, Starzynski RR, Stys A, et al. Iron homeostasis, a de- fense mechanism in oxidative stress. Postepy Biochem,2010,56: 305-316.
  • 2Ghoti H, Amer H,Winder A, et al. Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome. Eur J Haematol, 2007,79: 463- 467.
  • 3Fibach E, Rachmilewitz EA. The role of antioxidants and iron che- lators in the treatment of oxidative stress in thalassemia. Ann N Y Acad Sci, 2010, 1202:10 - 16.
  • 4Prus E, Fibach E. Effect of iron chelators on labile iron and oxida- tive status of thalassaemie erythroid cells. Acta Haematol,2010, 123 : 14 -20.
  • 5Messner DJ, Kowdley KV. Neoplastic transformation of rat liver ep- ithelial cells is enhanced by non-transferrin-bound iron. BMC Gas- troenterol,2008,8 : 2.
  • 6Prus E, Fibach E. Flow cytomeny measurement of the labile iron pool in human hematopoietic cells. Cytometry,2008,73:22-27.
  • 7Naka K, Muraguchi T, Hoshii T, et al. Regulation of reactive oxy- gen species and genomic stability in hematopoietic stem cells. An- tioxid Redox Signal, 2008, 10 : 1883-1894.
  • 8Bendova P, Mackova E, Haskova P, et al. Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury. Chem Res Toxicol, 2010, 23: 1105-1114.
  • 9Kong Y, Zhou S, Kihm AJ,et al. Loss of alpha-hemoglobin-stabi- lizing protein impairs erythropoiesis and exacerbates beta-thalasse- mia. J Clin Invest, 2004, 114: 1457-1466.
  • 10Ghaffari S. Oxidative stress in the regulation of normal and neo- plastic hematopoiesis. Antioxid Redox Signal, 2008, 10: 1923- 1940.

共引文献20

同被引文献64

  • 1Lu WY, Zhao MF,Xie F, et al. Free iron catalyzes oxidative dam- age to hematopoietic cells/mesenchymal stem ceils in vitro and sup- presses hematopoiesis in iron overload patients [ J ]. Eur J Haema- tol, 2013,91 (3) : 249-261.
  • 2Hartmann J, Braulke F, Sinzig U, et al. Iron overload impairs pro- liferation of erythrold progenitors cells (BFU-E) from patients with myelodysplastic syndromes [ J 1. Leuk Res, 2013,37 (3) :327-332.
  • 3Oliva EN, Ronco F, Marino A, et al. Iron chelation therapy asso- ciated with improvement of hematopoiesis in transfusion-dependent patients [J]. Transfusion, 2010,50 (7) : 1568-1570.
  • 4S6nehez-GonzOlez PD, L6pez-Hernandez FJ, Morales AI, et al. Effects of deferasirox on renal function and renal epithelial cell death[ J~. Toxicol Lett, 2011,203 (2) : 154-161.
  • 5Chaudhary P, Pullarkat V. Deferasirox appraisal of safety and effi- cacy in long-term therapy[ J~. Blood Med,2013,5 (4) :101-110.
  • 6Zhao MF, Xie F, Li YM, et al. Increased intracellular concentra- tionof reactive oxygen species mediated the deficienthematopoiesis of iron overload bone marrow [ J ]. Blood, 2010,116 ( 11 ) :42 -47.
  • 7Taoka K, Kumano K, Nakamura F, et al. The effect of ironover- load and chelation onerythroid differentiation [ J ]. Int J Hematol, 2012,95 (2) : 149-159.
  • 8Guafiqlia R, Martorelli MC, Villani O, et al. Positive effecton hematopoiesis in patients with myelodysplasticsydromereceiving de- ferasirox as oral iron chelation therapy: a briefreview [ J ]. Leuk Res, 2011,35(5) :566-570.
  • 9Taher AT, Musallam KM, Inati A. Iron overload: consequences, assessment, and monitoring[J] . Hemoglobin, 2009, 33 Suppl 1: S46-S57. DOl: 10.3109/0363026090334 6676.
  • 10Pullarkat V. Objectives of iron chelation therapy in myelodysplastic syndromes: more than meets the eye[J]. Blood, 2009, 114 ( 26) : 5251-5255. DOl: 10. 1182/blood-2009-07 -234062.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部